Additive Efficacy of a Bispecific Anti–TNF/IL-6 Nanobody Compound in Translational Models of Rheumatoid Arthritis

Combining anti-TNF and anti–IL-6 antibodies in collagen-induced arthritis mouse models resulted in sustained long-term remission, improved histology, and effects on bone remodeling pathways.